We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Biologic Data Analysis Software

By Biotechdaily staff writers
Posted on 31 Aug 2005
New data analysis software for researchers enables combined analysis of different data sets and facilitates biologic interpretation of results through public and local database retrieval.

The deCyder Extended Data Analysis (EDA) version 1.0, developed by GE Healthcare (Waukesha, WI, USA), adds accuracy to different gel electrophoresis (DIGE) studies by enhancing the analytic capabilities of the software.

"EDA v1.0 is a powerful, state-of-the-art 2D [two dimensional] DIGE software solution that offers advanced statistical analysis in an easy-to-use format,” said Kumar Bala, global marketing manager, GE Healthcare. More...
"This valuable analytical tool will contribute to a better understanding of regulatory pathways and help proteomics researchers more rapidly and accurately identify proteins to discriminate between healthy and disease tissue samples and different disease states and tumor types.”

The software employs multivariate analysis and advanced clustering techniques to reveal patterns in protein expression data derived from 2D DIGE experiments. The software employs a data set as the basis for 2D gel analysis. Each set of data, defined as a group of spot maps with correlated protein spots, can be displayed in different ways, depending on the objectives of the study.

The DeCyder EDA is a suitable tool for conducing biologic variance analysis (BVA) and can answer questions such as the following. How many groups or classes exist in a specific data set? Do any of the protein spots demonstrate similar characteristics, implying co-regulation? Are there proteins or protein patterns that appear to be characteristic of a biologic or disease state? Are those specific proteins that might be useful for the development of a noninvasive diagnostic or prognostic test?

The software was specifically designed as a vital element of the Ettan 2D DIGE technology platform. It identifies and accurately matches multiplexed fluorescent images produced from Ettan DIGE gels.




Related Links:
GE Healthcare

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.